ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 439

Analysis of Rheumatoid Arthritis Patients That Did Not Achieve the Treatment Goal By the Treat-to-Target Strategy in Daily Practice

Hideshi Yamazaki and Tetsuo Takanashi, Center for Rheumatic Disease, Marunouchi Hospital, Matsumoto, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: remission, rheumatoid arthritis (RA) and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Although the goal of rheumatoid arthritis (RA) treatment is to achieve remission or low disease activity with the treat-to-target (T2T) strategy, some patients do not achieve the goal in daily clinical practice. This study was performed to determine the reasons why these patients do not achieve the treatment goal.

Methods: A total of 504 patients with RA that were treated with the T2T strategy using electronic medical record system in 2014 – 2015 were investigated retrospectively. The patients had an average age of 63.7 years, and average disease duration of 15.9 years. A total of 144 patients were evaluated with moderate or high disease activity according to the simple disease activity index (SDAI) in 2014. After 1 year, 84 patients achieved the treatment goal, i.e., remission or low disease activity, while 60 patients still showed more than moderate disease activity and did not achieve the goal. In these patients, each item of SDAI, patient background, and treatment content were investigated.

Results:

In 2014, the patients that did not achieve the treatment goal in 2015 had significantly higher age, disease activity, tender joint count, patient global assessment, and HAQ-DI than the patients that did achieve the goal. In the patients that achieved the goal, all items of SDAI were significantly improved. In the patients that did not achieve the goal, swollen joint count and physician global assessment were significantly improved. As disease activity did not decrease, 21 patients were considered to have been treated insufficiently with the T2T strategy. Twenty-one patients had joint pain without arthritis. Eighteen patients were not treated sufficiently for complications, including six elderly patients, respiratory complications in eight patients, and others.

Conclusion:

Although the treatment goal of the T2T strategy in RA is remission or low disease activity, this goal is often not achieved in daily clinical practice. The patients that do not achieve the goal have higher disease activity or are not treated sufficiently with complications. It may be possible for these patients to achieve the goal by refining the treatment strategy or providing palliative treatment for pain. Additional T2T is necessary.


Disclosure: H. Yamazaki, None; T. Takanashi, None.

To cite this abstract in AMA style:

Yamazaki H, Takanashi T. Analysis of Rheumatoid Arthritis Patients That Did Not Achieve the Treatment Goal By the Treat-to-Target Strategy in Daily Practice [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/analysis-of-rheumatoid-arthritis-patients-that-did-not-achieve-the-treatment-goal-by-the-treat-to-target-strategy-in-daily-practice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-rheumatoid-arthritis-patients-that-did-not-achieve-the-treatment-goal-by-the-treat-to-target-strategy-in-daily-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology